FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073996 [Registered on: 18/09/2024] Trial Registered Prospectively
Last Modified On: 13/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study effect of Intravenous Magnesium Sulphate administration on Postoperative Analgesia in infraumbilical surgeries under spinal anaesthesia. 
Scientific Title of Study   Effects of intravenous magnesium suphate administration on postoperative analgesia in infraumbilical surgeries under spinal anaesthesia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Subhashree Jena 
Designation  JUNIOR RESIDENT 
Affiliation  Dr D.Y. Patil Medical College, Hospital and Research Centre 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Pune
MAHARASHTRA
411018
India 
Phone  9348212504  
Fax    
Email  sjena.128.sj@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shahbaz Hasnain  
Designation  Professor, Department of Anaesthesiology 
Affiliation  DR D.Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Pune
MAHARASHTRA
411018
India 
Phone  9764621253  
Fax    
Email  shahbazhsnn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shahbaz Hasnain 
Designation  Professor, Department of Anaesthesiology 
Affiliation  DR D.Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune
Pune
MAHARASHTRA
411018
India 
Phone  9764621253  
Fax    
Email  shahbazhsnn@gmail.com  
 
Source of Monetary or Material Support  
Central pharmacy, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra, India Pincode-411018 
 
Primary Sponsor  
Name  Subhashree Jena 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subhashree Jena  Dr. D.Y. Patil Hospital and Research Centre  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr D.Y. Patil Medical College, Hospital and Reseach Centre, Sant Tukaram Nagar, Pimpri, Pune 411018
Pune
MAHARASHTRA 
9348212504

sjena.128.sj@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Sub-Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Magnesium Sulphate  In the study group 0.5ml (250mg) of Inj. Magnesium Sulphate IV was given, followed by 500mg (25mg/ml) infusion was given at 20ml/hr for 1hour through intravenous route. In the control group 0.5ml NS will be given IV followed by infusion at 20ml/hr. 
Comparator Agent  Normal saline  same volume of normal saline as bolus and infusion was given 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients aged 18-65years, undergoing lower abdominal surgeries
BMI 20-35 kg/m2
ASA Grade I and II
Mallampati Score Class I and II
Patients giving consent to be part of the study
Hemodynamically Stable Patients
Routine Investigations (CBC, RFT, LFT, SE)- within normal limits
Duration of Surgery less than 4 hours
 
 
ExclusionCriteria 
Details  Patients unwilling to Consent
Patients with ASA Grade III or IV
Hemodynamical Instability (Hypotension, Bradycardia)
Severe or Uncontrolled Diabetes or Hypertension, CVD
Cardiovasular Disease (CAD, HF, Cardiomyopathies, Valvular Heart Diseases)
Hepatic Impairment, Renal Impairment
Known case of Coagulopathies, abnormal hemoglobin, Anaemia
Known case of Kyphoscoliosis and deformity of spine

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
To study effect of Intravenous Magnesium Sulphate administration on postoperative ananlgesia in infraumbilical surgeries under spinal anaesthesia  After administration of the spinal anaesthesia, comparison between the two groups of onset and duration of sensory and motor blockade, duration of analgesia and time of rescue of analgesia will be assessed at baseline, after injection of study drug at immediate postop, 15mins, 30mins, 45mins, 60minms, 4hrs, 8hrs, 12hrs, 16hrs, 20hrs, 24hrs and assessment VAS score  
 
Secondary Outcome  
Outcome  TimePoints 
To study effect of Intravenous Magnesium Sulphate administration on postoperative ananlgesia in infraumbilical surgeries under spinal anaesthesia  Duration of analgesia will be assessed post surgery after administration of magnesium sulphate & time of rescue analgesia will be assessed 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   24/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  24/09/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is randomized and double blinded prospective study to evaluate the postoperative analgesic effect of Magnesium sulphate by perioperative administration via intravenous route and Intra-operative assessment of HR, BP, Spo2, RR, Input-Output was done. Postoperatively, the patients were assessed using VAS every 4 hours for 24hours. The Heart rate, Blood Pressure and MAP, Respiratory rate and SpO2 were also assessed every 4 hours for 24 hours. The secondary endpoints included assessment of the requirement of rescue analgesia and assessment of hemodynamic effects of magnesium administration in infraumbilical surgeries under spinal anaesthesia 
Close